PTX3 and systemic inflammatory response syndrome: Assessed by ROC analysis, serum concentrations of PTX3 at time of admission were sufficiently specific (85.0%) and sensitive (89.1%) to discriminate between healthy controls and SIRS (area under the curve (AUC) 0.922 (95% CI 0.892 to 0.946, p<0.0001).